US STOCKS-Dow ends at record high; Apple drags on S&P 500, Nasdaq
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
[Reuters] – U.S. health regulators on Thursday approved a blood clot preventer developed by Merck & Co for use by patients who have had a heart attack or who suffer from blockages in the arteries of the legs. The drug, vorapaxar, was approved to reduce t moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click […]
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck is hiring next, click here to view […]
[Business Wire] – AiCuris and Merck , known as MSD outside the United States and Canada, today announced the publication of results from a Phase 2 clinical trial evaluating the safety and efficacy of letermovir, an investigational, oral antiviral agent f moreView todays social media effects on MRKView the latest stocks trending across Twitter. Click to view dashboardSee who Merck […]